Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
  1. 144 Insider Sale of Securities
  2. 4 Open-market sale SVP, CHIEF ACCOUNTING OFFICER sold 12,090 shares at $18.30 ($221,258)
  3. 144 Insider Sale of Securities
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. 8-K Event Other events
  10. 424B5 Offering Prospectus
  11. 424B5 Offering Prospectus
  12. SC 13G/A Stake Amended Statement of Ownership
  13. 424B5 Offering Prospectus
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. SC 13G/A Stake Amended Statement of Ownership
  17. 4 Planned sale Director sold 40,000 shares at an average $14.73 ($589,101)
  18. 144 Insider Sale of Securities
  19. 4 Planned sale Director sold 40,000 shares at $14.06 ($562,324)
  20. 144 Insider Sale of Securities

Page 16 of 65 · 1,286 filings